FOLD
Amicus Therapeutics Inc
Price:  
9.77 
USD
Volume:  
1,572,452.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

FOLD WACC - Weighted Average Cost of Capital

The WACC of Amicus Therapeutics Inc (FOLD) is 8.2%.

The Cost of Equity of Amicus Therapeutics Inc (FOLD) is 8.20%.
The Cost of Debt of Amicus Therapeutics Inc (FOLD) is 8.80%.

Range Selected
Cost of equity 6.80% - 9.60% 8.20%
Tax rate 1.00% - 1.50% 1.25%
Cost of debt 7.00% - 10.60% 8.80%
WACC 6.8% - 9.7% 8.2%
WACC

FOLD WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.63 0.84
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.80% 9.60%
Tax rate 1.00% 1.50%
Debt/Equity ratio 0.13 0.13
Cost of debt 7.00% 10.60%
After-tax WACC 6.8% 9.7%
Selected WACC 8.2%